In a world that continues to face significant health, economic, social justice and humanitarian challenges, I couldn’t be prouder of Thermo Fisher’s role in addressing them. We are the world leader in serving science, and our responsibility encompasses both our commitment to our customers and the impact we have through our business practices and involvement... Read more
Secure, SaaS informatics platform drives streamlined workflows and accelerated decision-making for pharmaceutical and industrial customers WALTHAM, Mass. – October 25, 2021– PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its Signals Research™ Suite , a full cloud based solution, deployed on Amazon Web Services. The... Read more
The AVENIO Tumor Tissue Comprehensive Genomic Profiling (CGP) Kit is the first jointly-developed product that brings together the expertise and reach of Roche with Foundation Medicine’s pioneering leadership in genomic science. This is the first time that research scientists can conduct oncology research with Foundation Medicine’s comprehensive genomic profiling in their own laboratories to gain... Read more
Upper left: Prof. Takeo Yoshikawa, RIKEN Center for Brain Science; Upper right: Prof. Nobutaka Hirokawa, University of Tokyo; Lower, members of Dr. Hirokawa’s lab – from left to right – Dr. Momo Morikawa, Shogo Yoshihara and Dr. Yosuke Tanaka. Schizophrenia is a mental disorder in which patients often suffer hallucinations, delusions and disordered thinking that... Read more
FRANKLIN LAKES, N.J., Oct. 22, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Dr. Carrie L. Byington has been appointed to the company’s board of directors, bringing the total number of directors to 13. Byington, 58, is executive vice president and head of University of California Health (UCH), where she... Read more
Susvimo, previously called Port Delivery System with ranibizumab, is the first nAMD treatment in 15 years to provide an alternative to standard-of-care eye injections needed as often as once a month By continuously delivering medicine into the eye through a refillable implant, Susvimo may help people with nAMD maintain their vision with as few as... Read more
Chicago – October 22, 2021: At this year’s ASTRO 2021 event, GE Healthcare will showcase over 15 innovative multi-modality radiation therapy solutions, offering medical practitioners imaging tools and support they need to improve patient-centered care and advance the practice of precision medicine. “GE Healthcare aims to drive improved patient outcomes through cutting-edge multi-modality radiation therapy... Read more
Lung cancer remains the leading cause of cancer-related deaths worldwide, with more than 2.2 million people diagnosed globally last year.1 The VENTANA PD-L1 (SP263) Assay helps determine which non-small cell lung cancer patients may benefit from treatment with Tecentriq immunotherapy based on the results of the Phase III IMpower010 study. This new test expands Roche’s... Read more
SANTA CLARA, Calif., October 21, 2021 Agilent Technologies Inc. (NYSE: A) today announced it has received CE-IVD mark approval for the PD-L1 IHC 28-8 pharmDx to guide options for the first-line treatment of adult patients with HER2-negative advanced or metastatic gastric, gastroesophageal junction, or esophageal cancers. Gastric (stomach) cancer is the fifth most common cancer and... Read more
Global Partnership Scales Imagine H2O’s Work with Entrepreneurial Water Solutions RYE BROOK, N.Y.–(BUSINESS WIRE)–Oct. 21, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s greatest water challenges has announced an expanded commitment to Imagine H2O, the leading water innovation accelerator and ecosystem for water entrepreneurs. As a global... Read more